Global Recombinant Non-Glycosylated Proteins Biosimilars Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI398704
- May 03, 2019
- Global
- 94 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Recombinant Non-Glycosylated Proteins Biosimilars market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Recombinant Non-Glycosylated Proteins Biosimilars market."
Recombinant non-glycosylated proteins include human growth hormone, granulocyte colony-stimulating factor, interferons, and insulin. The statistic scope in this report is Recombinant non-glycosylated proteins biosimilars.
The global Recombinant Non-Glycosylated Proteins Biosimilars market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Recombinant Non-Glycosylated Proteins Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Non-Glycosylated Proteins Biosimilars market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddys Laboratories
Stada Arzneimittel AG
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Insulin
rHGH
Interferon
Segment by Application
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
Table of Contents
Executive Summary
1 Recombinant Non-Glycosylated Proteins Biosimilars Market Overview
1.1 Product Overview and Scope of Recombinant Non-Glycosylated Proteins Biosimilars
1.2 Recombinant Non-Glycosylated Proteins Biosimilars Segment by Type
1.2.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Insulin
1.2.3 rHGH
1.2.4 Interferon
1.3 Recombinant Non-Glycosylated Proteins Biosimilars Segment by Application
1.3.1 Recombinant Non-Glycosylated Proteins Biosimilars Consumption Comparison by Application (2014-2025)
1.3.2 Oncology
1.3.3 Chronic Diseases
1.3.4 Autoimmune Diseases
1.3.5 Blood Disorders
1.3.6 Growth Hormone Deficiency
1.3.7 Infectious Diseases
1.3.8 Other Diseases
1.4 Global Recombinant Non-Glycosylated Proteins Biosimilars Market by Region
1.4.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Size
1.5.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue (2014-2025)
1.5.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Production (2014-2025)
2 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Competition by Manufacturers
2.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Market Share by Manufacturers (2014-2019)
2.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue Share by Manufacturers (2014-2019)
2.3 Global Recombinant Non-Glycosylated Proteins Biosimilars Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Recombinant Non-Glycosylated Proteins Biosimilars Production Sites, Area Served, Product Types
2.5 Recombinant Non-Glycosylated Proteins Biosimilars Market Competitive Situation and Trends
2.5.1 Recombinant Non-Glycosylated Proteins Biosimilars Market Concentration Rate
2.5.2 Recombinant Non-Glycosylated Proteins Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Market Share by Regions
3.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Market ...
| read more...
Related Reports
